At a glance
ClinicalIndex Comparison RecordN/ACompleted· 100 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Subclinical Impairment of Cardiovascular System in Patients With Psoriasis
In Brief
An observational study for Psoriasis and 6 related conditions. Completed, enrolled 100 participants across 1 site.
Detailed Summary
A cross-sectional study will be conducted, which will include 80 young patients with psoriasis, aged 30-45 years, treated with five different types of antipsoriatic treatment, and 20 healthy patients. All 100 subjects will be subjected to anthropometric measurements, blood will be collected for laboratory tests, and an imaging test will be performed to determine the function of the endothelium and arterial stiffness. The results will then be statistically analyzed.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsPsoriasis, Inflammation, Endothelial Dysfunction, Metabolic Disturbance, Insulin Resistance, Coagulation Disorder, Thrombocyte Disorders
CountriesSlovenia
Collaborators--
Timeline
N/ACompletedFinished
20222023202420252026
Enrollment StartJan 2022
Primary CompletionSep 2022
Study CompletionNov 2022
First PostedJul 2023
TodayJul 2026
First PostedJul 24, 2023
Enrollment StartJan 3, 2022
Primary CompletionSep 1, 2022
Study CompletionNov 30, 2022
TodayJul 2, 2026
Enrollment to primary: 8 monthsPosted 2.9 years ago